Butterfly Network, Inc. (BFLY) Financial Ratio Screen

NYSE Healthcare United States USD 998M
RATIOS FAIL*
Automated financial screen · activity assessed separately
Butterfly Network, Inc. (BFLY) is potentially non-compliant in the automated ratio model. While the debt ratio of 6.9% is acceptable, the cash and interest-bearing securities ratio of 50.7% exceeds the 30% threshold. Butterfly Network, Inc. operates in the Healthcare sector.

Track BFLY screening changes

Get an email when this stock's published screening status or underlying ratios change.

MSCI new-inclusion financial-ratio snapshot

BFLY financial screening at a glance

RATIOS FAIL*Financial ratios shown separately from business review — not a fatwa
Debt ratio
6.9%
Pass vs 30%
Cash ratio
50.7%
Fail vs 30%
Receivables + cash
59.8%
Fail vs 30%
Impermissible income
6.1%
Fail vs 5%

Calculation date: 2026-08-31. Financial period used: December 2025. The ratios are automated proxies inspired by published methodologies; they are not official index determinations.

Independent method comparison

What the available screens say

How MSCI, FTSE and S&P-style screens differ
Request this stock review
MSCI-styleFinancial criteria not metAt least one available ratio exceeds its threshold
FTSE/Yasaar-styleFinancial criteria not metAt least one available ratio exceeds its threshold
S&P-style provisionalNot yet availableRequired denominator or financial data is incomplete
Business activityAssessment pendingFinancial results do not determine business permissibility
Complete screening result: not yet completeA complete result requires both supported financial criteria and adequate activity evidence. This site does not issue a fatwa or official index decision.
Financial periodDecember 2025Calculation date2026-08-31S&P-style historynot availableLast activity reviewnot yet reviewed

The request button opens your email application with a pre-filled message. HalalStockGuide receives no address or request unless you choose to send it.

Business activity evidence

Activity assessment in progress

The supplied classification (Medical Devices) is only a starting point. Revenue evidence is being assessed before any complete screening conclusion.

Revenue segments: Not yet checked against an SEC annual filing.

Profile description reviewed: Butterfly Network, Inc. develops, manufactures, and commercializes ultrasound imaging solutions in the United States and internationally. The company offers Butterfly iQ+ and iQ3 ultrasound devices that can perform whole-body imaging on a single handheld probe integrated with the clinical workflow, and accessible on a user's smartphone, tablet, and almost any hospital computer system; Butterfly Move, merging the mobility of a handheld with the stability of a full cart system; and iQ+ Bladder, a specialty product for bladder scanning market. It also provides Compass AI which offers one system to connect every device, workflow, and department; ScanLab, an AI-powered educational platform that provides written walkthroughs and reference imagery to guide real-time educational scanning; and Butterfly iQ+/iQ3 Vet, a third generation handheld ultrasound system. It sells and markets its products through a direct sales force, distributors, and e-commerce channels. Butterfly Network, Inc. was founded in 2011 and is headquartered in Burlington, Massachusetts.

Sources to verify: Secondary company profile and classification · Issuer website · SEC issuer filings

A sector label or company description can flag a risk but cannot establish a compliant-revenue percentage. Only sourced segment disclosures may support that calculation.

Published-ratio reproductions (not certifications)

The table shows implemented MSCI and FTSE/Yasaar-style asset-based models plus a provisional S&P-style leverage reconstruction where a complete 36-month denominator exists. These are independent calculations, not official index results or Shariah determinations. See formulas, sources and limitations.

Based on financial data from December 2025

Standard Debt Ratio Cash Ratio Receivables Income Status
MSCI 6.9%
/ 30%
50.7%
/ 30%
59.8%
/ 30%
6.06%
/ 5%
RATIOS FAIL*
FTSE 6.9%
/ 33%
50.7%
/ 33%
59.8%
/ 50%
6.06%
/ 5%
RATIOS FAIL*

Financial Highlights

EPS
$-0.31
P/B Ratio
5.1
EV/EBITDA
-16.0
EV: $868M
Revenue
$98M
Growth: 41.0%
Beta
2.3
High volatility
Current Ratio
3.8

Profitability

Gross Margin 64.7%
Operating Margin -36.1%
Net Margin -79.0%
Return on Equity (ROE) -42.2%
Return on Assets (ROA) -13.2%

Cash Flow & Balance Sheet

Operating Cash Flow-$13M
Free Cash Flow-$16M
Total Debt$20M
Debt-to-Equity10.4
Current Ratio3.8
Total Assets$297M

Price & Trading

Last Close$4.15
50-Day MA$3.80
200-Day MA$2.69
Avg Volume6.0M
Beta2.3
52-Week Range
$1.32
$5.03

Financial data provenance and verification

The displayed fields were imported from yfinance on 2026-03-29 for the financial period December 2025. This is a secondary data feed and can differ from amended or newly filed statements.

Verification rule: check debt, cash, receivables, revenue and interest income against the latest primary filing before relying on an automated ratio.

About Butterfly Network, Inc. (BFLY)

CEO
Mr. Joseph M. DeVivo
Employees
220
Sector
Healthcare
Industry
Medical Devices
Country
United States
Exchange
NYSE
Market Cap (listing currency)
USD 998M
Currency
USD

Butterfly Network, Inc. develops, manufactures, and commercializes ultrasound imaging solutions in the United States and internationally. The company offers Butterfly iQ+ and iQ3 ultrasound devices that can perform whole-body imaging on a single handheld probe integrated with the clinical workflow, and accessible on a user's smartphone, tablet, and almost any hospital computer system; Butterfly Move, merging the mobility of a handheld with the stability of a full cart system; and iQ+ Bladder, a specialty product for bladder scanning market. It also provides Compass AI which offers one system to connect every device, workflow, and department; ScanLab, an AI-powered educational platform that provides written walkthroughs and reference imagery to guide real-time educational scanning; and Butterfly iQ+/iQ3 Vet, a third generation handheld ultrasound system. It sells and markets its products through a direct sales force, distributors, and e-commerce channels. Butterfly Network, Inc. was founded in 2011 and is headquartered in Burlington, Massachusetts.

Popular halal stock checks

Explore other frequently viewed automated stock screens and compare the available financial ratios.

Frequently Asked Questions

Is Butterfly Network, Inc. (BFLY) halal to invest in?

The current automated result is Financial criteria not met or an activity exclusion was detected. It uses available public financial fields and simplified methodology proxies. It is not a fatwa or an official determination by AAOIFI, DJIM, MSCI, S&P, or FTSE.

What is Butterfly Network, Inc.'s debt ratio?

Butterfly Network, Inc.'s debt ratio is 6.9% in the MSCI new-inclusion reproduction: total debt divided by total assets, against a 30% threshold. See the methodology page for the official source and limitations.

What are Butterfly Network, Inc.'s key financial metrics?

Butterfly Network, Inc. has a market capitalization of USD 998M in its listing currency, and revenue of $98M. The company maintains a gross margin of 64.7% and a net margin of -79.0%. Return on equity stands at -42.2%.

How often is the screening data updated?

Calculation date: 2026-08-31. Financial period: December 2025. These dates are shown separately because regenerating this page does not refresh the underlying data.

Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.